drug

PV-001

Preclinicalupdated 3mo ago

by Primevax Immuno Oncology Inc

Preclinical

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying PV-001

phase1Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanomaunknownn=10
phase1Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanomaunknownn=10
phase1Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanomaunknownn=10

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

PV-001

Preclinicalupdated 3mo ago

by Primevax Immuno Oncology Inc

Preclinical

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying PV-001

phase1Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanomaunknownn=10
phase1Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanomaunknownn=10
phase1Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanomaunknownn=10

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

PV-001

indications

all catalysts(0)

Trials studying PV-001

News(0)

Report a data issue

comments(0)

PV-001

indications

all catalysts(0)

Trials studying PV-001

News(0)

Report a data issue

comments(0)